teamphresearch

The Team PHenomenal Hope Award Program

The Team PHenomenal Hope Award Program rewards studies of novel concepts in PH with a potential to transform the field. This is not limited to any PH groups, pediatrics, or adult studies. Eventual clinical applicability is expected. As such, this program will provide an opportunity for individuals to affect the quality of medical care and improve the lives of patients with pulmonary hypertension.

For our 2025 Research Award, we are especially looking for topics that will help expand access to care and improve clinical status by looking specifically for projects in the topic areas outlined at the 2024 PHenomenal Hope research symposium in Boston. Click on Program Overview to learn more.

Congratulations to Dr. Jason Weatherald, 2024 award winner, for his submission titled, "A feasibility trial for the Canadian Right ventricular AdaptiVE (CRAVE) platform trial of therapies targeting right ventricular failure."